1. SawayaF, LiffD, StewartJ, et al.Aortic stenosis: a contemporary review. Am J Med Sci2012;343:490. CrossRef

2. WarkentinTE, MooreJC. Heyde's syndrome: from controversy to mainstream. Thromb Haemost2010;103:251. CrossRef

3. KingRM, PluthJR, GiulianiER. The association of unexplained gastrointestinal bleeding with calcific aortic stenosis. Ann Thorac Surg1987;44:514. CrossRef

4. LoveJW. The syndrome of calcific aortic stenosis and gastrointestinal bleeding: resolution following aortic valve replacement. J Thorac Cardiovasc Surg1982;83:779.

5. PanzerS, Badr EslamR, SchnellerA, et al.Loss of high‐molecular‐weight von Willebrand factor multimers mainly affects platelet aggregation in patients with aortic stenosis. Thromb Haemost2010;103:408. CrossRef

6. BuchiKN. Vascular malformations of the gastrointestinal tract. Surg Clin North Am1992;72:559.

7. SchmitA, GayF, AdlerM, et al.Diagnostic efficacy of push‐enteroscopy and long‐term follow‐up of patients with small bowel angiodysplasias. Dig Dis Sci1996;41:2348. CrossRef

8. McMurrayJJ, PfefferMA. Heart failure. Lancet2005;365:1877. CrossRef

9. LevineJS, JacobsonED. Intestinal ischemic disorders. Dig Dis1995;13:3. CrossRef

10. KingD, SmithML, ChapmanTJ, et al.Fat malabsorption in elderly patients with cardiac cachexia. Age Ageing1996;25:144. CrossRef

11. DavidsonJD, WaldmannTA, GoodmanDS, et al.Protein‐losing gastroenteropathy in congestive heart‐failure. Lancet1961;1:899. CrossRef

12. KuboSH, WalterBA, JohnDH, et al.Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics. Arch Intern Med1987;147:1227. CrossRef

13. ArcidiJMJr, MooreGW, HutchinsGM. Hepatic morphology in cardiac dysfunction: a clinicopathologic study of 1000 subjects at autopsy. Am J Pathol1981;104:159.

14. OuditGY, Dill‐MackyMJ, AllardJP. Image of the month. Gastroenterology2000;119:1190. CrossRef

15. BakerDW, KonstamMA, BottoroffM, et al.Management of heart failure. JAMA1994;272:1361. CrossRef

16. LevinskyRA, LewisRM, BynumTE, et al.Digoxin induced intestinal vasoconstriction: the effects of proximal artery stenosis and glucagon administration. Circulation1975;52:130. CrossRef

17. EckhauserML, DoklerM, ImbemboAL. Diuretic‐associated pancreatitis: a collective review and illustrative cases. Am J Gastroenterol1987;82:865.

18. BarloonTJ, MorreSA, MitrosFA. A case of stenotic obstruction of the jejunum secondary to slow‐release potassium. Am J Gastroenterol1986;81:192.

19. World Health Organization, World Heart Federation, World Stroke Organization. Global atlas on cardiovascular disease prevention and control: policies, strategies, and interventions. Published2011. Available at: http://www.who.int/cardiovascular_diseases/publications/atlas_cvd/en/.

20. LagergrenJ, BergströmR, AdamiHO, et al.Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med2000;133:165. CrossRef

21. CalderonRM, CubedduLX, GoldbergRB, et al.Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma. Mayo Clin Proc2010;85:349. CrossRef

22. EkstedtM, FranzénLE, MathiesenUL, et al.Statins in non‐alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow‐up study. J Hepatol2007;47:135. CrossRef

23. SinghS, SinghPP, SinghAG, et al.Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta‐analysis. Gastroenterology2013;144:323. CrossRef

24. BardouM, BarkunA, MartelM. Effect of statin therapy on colorectal cancer. Gut2010;59:1572. CrossRef

25. SinghH, MahmudSM, TurnerD, et al.Long‐term use of statins and risk of colorectal cancer: a population‐based study. Am J Gastroenterol2009;104:3015. CrossRef

26. LiuY, TangW, WangJ, et al.Association between statin use and colorectal cancer risk: a meta‐analysis of 42 studies. Cancer Causes Control2014;25:237. CrossRef

27. PatronoC. Aspirin as an antiplatelet drug. N Engl J Med1994;330:1287. CrossRef

28. BeckerRC, ScheimanJ, DauermanHL, et al.Management of platelet‐directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. J Am Coll Cardiol2009;54:2261. CrossRef

29. BhattDL, FoxKA, HackeW, et al.Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med2006;354:1706. CrossRef

30. BhattDL, ScheimanJ, AbrahamNS, et al.ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol2008;52:1502. CrossRef

31. AbrahamNS, HlatkyMA, AntmanEM, et al.ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol2010;105:2533. CrossRef

32. American Society of Gastrointestinal Endoscopy (ASGE). Management of antithrombotic agents for endoscopic procedures. Gastroinest Endosc2009;70:1060. CrossRef

33. GulerM, YamakB, ErdoganM, et al.Risk factors for gastrointestinal complications in patients undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth2011;25:637. CrossRef

34. GordonDA, JamilM. Progress towards understanding the role of microsomal triglyceride transfer protein in apolipoprotein‐B lipoprotein assembly. Biochim Biophys Acta2000;1486:72. CrossRef

35. Di LeoE, LancellottiS, PenacchioniJY, et al.Mutations in MTP gene in abeta‐ and hypobeta‐lipoproteinemia. Atherosclerosis2005;180:311. CrossRef

36. FridC, DrottP, LundellB, et al.Mortality in Down's syndrome in relation to congenital malformations. J Intellect Disabil Res1999;43:234. CrossRef

37. BrownRA, MillarAJ, LinegarA, et al.Fenestrated duodenal membranes: an analysis of symptoms, signs, diagnosis, and treatment. J Pediatr Surg1994;29:429. CrossRef

38. BookL, HartA, BlackJ, et al.Prevalence and clinical characteristics of celiac disease in Down's syndrome in a US study. Am J Med Genet A2001;98:70. CrossRef

39. SchiffmannR, KoppJB, AustinHAIII, et al.Enzyme replacement therapy in Fabry disease. JAMA2001;285:2743. CrossRef

40. DesnickRJ, BradyR, BarrangerJ, et al.Fabry disease, an underrecognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme‐replacement therapy. Ann Intern Med2003;138:388. CrossRef

41. HofmannB, ReinhardtD, KoletzkoB. Effect of enzyme‐replacement therapy on gastrointestinal symptoms in Fabry disease. Eur J Gastroenterol Hepatol2004;16:1067. CrossRef

42. EisenbergS, AksentijevichI, DengZ, et al.Diagnosis of familial Mediterranean fever by a molecular genetics method. Ann Intern Med1998;129:539. CrossRef

43. DrenthJPH, van der MeerJWM. Hereditary periodic fevers. N Engl J Med2001;345:1748. CrossRef

44. CerquagliaC, DiacoM, NuceraG, et al.Pharmacological and clinical basis of treatment of familial Mediterranean fever (FMF) with colchicines or analogues: an update. Curr Drug Targets Inflamm Allergy2005;4:117. CrossRef

45. CharrowJ, AnderssonHC, KaplanP, et al.The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease. Arch Intern Med2000;160:2835. CrossRef

46. GermainDP. Gaucher's disease: a paradigm for interventional genetics. Clin Genet2004;65:77. CrossRef

47. AndersonKE, BloomerJR, BonkovskyHL, et al.Recommendations for the diagnosis and treatment of the acute porphyries. Ann Intern Med2005;142:439. CrossRef

48. ZadraM, GrandiR, ErliLC, et al.Treatment of seizures in acute intermittent porphyria: safety and efficacy of gabapentin. Seizure1998;7:415. CrossRef

49. SarkanyRP. Porphyria. From Sir Walter Raleigh to molecular biology. Adv Exp Med Biol1999;455:235. CrossRef

50. GompelsMM, LockRJ, AbinunM, et al.C1 inhibitor deficiency: consensus document. Clin Exp Immunol2005;139:379. CrossRef

51. PeersonKD, BuchignannJS, ShimkinPM, et al.Hereditary angioneurotic edema of the gastrointestinal tract. AJR Am J Roentgenol1972;116:256. CrossRef

52. WassersteinMP, DesnickRJ, SchuchmanEH, et al.The natural history of type B Neimann–Pick disease: results from a 10‐year longitudinal study. Pediatrics2004;114:672. CrossRef

53. RustS, WalterM, FunkeH, et al.Asignment of Tangier disease to chromosome 9q31 by a graphical linkage exclusion strategy. Nat Genet1998;20:96. CrossRef

54. OramJF. Molecular basis of cholesterol hemostasis: lessons from Tangier disease and ABCA1. Trends Mol Med2002;8:168. CrossRef

55. SybertVP, McCauleyE. Turner's syndrome. N Engl J Med2004;351:1227. CrossRef

56. AlbaredaMM, GallegoA, EnriquezJ, et al.Biochemical liver abnormalities in Turner's syndrome. Eur J Gastroenterol Hepatol1999;11:1037. CrossRef

57. ZbarB, KaelinW, MaherE, et al.Third international meeting on von Hippel Lindau disease. Cancer Res1999;59:2251.

58. HammelPR, VilgrainV, TerrisB, et al.Pancreatic involvement in von Hippel Lindau disease. Gastroenterology2000;119:1087. CrossRef

59. LeRoyEC, BlackC, FleischmajerR, et al.Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol1988;15:202.

60. EbertEC. Esophageal Disease in Scleroderma. J Clin Gastroenterol2006;40:769. CrossRef

61. SjogrenRW. Gastrointestinal features of scleroderma. Curr Opin Rheumatol1996;8:569. CrossRef

62. GygerG, BaronM. Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management. Curr Rheumatol Rep2012;14:22. CrossRef

63. MarieI, GourcerolG, LeroiAM, et al.Delayed gastric emptying determined using the 13C‐octanoic acid breath test in patients with systemic sclerosis. Arthritis Rheum2012;64:2346. CrossRef

64. ZamostBJ, HirschbergJ, IppolitiAF, et al.Esophagitis in scleroderma. Prevalence and risk factors. Gastroenterology1987;92:421.

65. de CarvalhoME, KairallaRA, CapelozziVL, et al.Centrilobular fibrosis: a novel histological pattern of idiopathic interstitial pneumonia. Pathol Res Pract2002;198:577. CrossRef

66. SelingerCP, AngYS. Gastric antral vascular ectasia (GAVE): an update on clinical presentation, pathophysiology and treatment. Digestion2008;77:131. CrossRef

67. SchulzSW, O'BrienM, MaqsoodM, et al.Improvement of severe systemic sclerosis‐associated gastric antral vascular ectasia following immunosuppressive treatment with intravenous cyclophosphamide. J Rheumatol2009;36:1653. CrossRef

68. BacherA, MittooS, HudsonM, et al.Systemic sclerosis in Canada's North American Native population: assessment of clinical and serological manifestations. J Rheumatol2013;40:1121. CrossRef

69. ParodiA, SessaregoM, GrecoA, et al.Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication. Am J Gastroenterol2008;103:1257. CrossRef

70. PerlemuterG, CacoubP, ChaussadeS, et al.Octreotide treatment of chronic intestinal pseudoobstruction secondary to connective tissue diseases. Arthritis Rheum1999;42:1545. CrossRef

71. Franck‐LarssonK, GrafW, RönnblomA. Lower gastrointestinal symptoms and quality of life in patients with systemic sclerosis: a population‐based study. Eur J Gastroenterol Hepatol2009;21:176. CrossRef

72. ThouaNM, SchizasA, ForbesA, et al.Internal anal sphincter atrophy in patients with systemic sclerosis. Rheumatology (Oxford)2011;50:1596. CrossRef

73. AlamanosY, DrososAA. Epidemiology of adult rheumatoid arthritis. Autoimmun Rev2005;4:130. CrossRef

74. ArnettFC, EdworthySM, BlochDA, et al.The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum1988;31:315. CrossRef

75. MaloneDE, McCormickPA, DalyL, et al.Peptic ulcer in rheumatoid arthritis–intrinsic or related to drug therapy?Br J Rheumatol1986;25:342. CrossRef

76. de WitteTJ, GeerdinkPJ, LamersCB, et al.Hypochlorhydria and hypergastrinaemia in rheumatoid arthritis. Ann Rheum Dis1979;38:14. CrossRef

77. KobayashiH, TadaS, FuchigamiT, et al.Secondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy. Br J Rheumatol1996;35:44. CrossRef

78. EbertEC, HagspielKD. Gastrointestinal and hepatic manifestations of rheumatoid arthritis. Dig Dis Sci2011;56:295. CrossRef

79. DenisMA, CosynsJP, PersuA, et al.Control of AA amyloidosis complicating Crohn's disease: a clinico‐pathological study. Eur J Clin Invest2013;43:292. doi: 10.1111/eci.12045; [Epub 2013 Feb 4]. CrossRef

80. HakalaM, ImmonenK, KorpelaM, et al.Good medium‐term efficacy of tocilizumab in DMARD and anti‐TNF‐α therapy resistant reactive amyloidosis. Ann Rheum Dis2013;72:464. CrossRef

81. BilgenSA, KilicL, AkdoganA, et al.Effects of anti‐tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and/or sacroiliitis who were resistant to colchicine treatment. J Clin Rheumatol2011;17:358. CrossRef

82. ThorneC, UrowitzMB, WanlessI, et al.Liver disease in Felty's syndrome. Am J Med1982;73:35. CrossRef

83. PagnouxC, MahrA, CohenP, et al.Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg‐Strauss syndrome, or rheumatoid arthritis‐associated vasculitis. Medicine (Baltimore)2005;84:115. CrossRef

84. LaineL. Nonsteroidal anti‐inflammatory drug gastropathy. Gastrointest Endosc Clin N Am1996;6:489.

85. SinghG, RameyDR, MorfeldD, et al.Gastrointestinal tract complications of nonsteroidal anti‐inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study. Arch Intern Med1996;156:1530. CrossRef

86. BombardierC, LaineL, ReicinA, et al.Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med2000;343:1520. CrossRef

87. LanzaFL, ChanFK, QuigleyEM, et al.Guidelines for prevention of NSAID‐related ulcer complications. Am J Gastroenterol2009;104:728. CrossRef

88. MyasoedovaE, MattesonEL, TalleyNJ, et al.Increased incidence and impact of upper and lower gastrointestinal events in patients with rheumatoid arthritis in Olmsted County, Minnesota: a longitudinal population‐based study. J Rheumatol2012;39:1355. CrossRef

89. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum2002;46:328. CrossRef

90. LosekJD, WerlinSL. Sulfasalazine hepatotoxicity. Am J Dis Child1981;135:1070.

91. Vergara‐FernandezO, Zeron‐MedinaJ, Mendez‐ProbstC, et al.Acute abdominal pain in patients with systemic lupus erythematosus. J Gastrointest Surg2009;13:1351. CrossRef

92. JuJH, MinJK, JungCK, et al.Lupus mesenteric vasculitis can cause acute abdominal pain in patients with SLE. Nat Rev Rheumatol2009;5:273. CrossRef

93. DiepJT, KerrLD, SarebahiS, et al.Opportunistic infections mimicking gastrointestinal vasculitis in systemic lupus erythematosus. J Clin Rheumatol2007;13:213. CrossRef

94. MoscaM, TaniC, FiliceME, et al.TNF‐alpha inhibitors in Systemic Lupus Erythematosus. A case report and a systematic literature review. Mod Rheumatol2013. [Epub ahead of print] doi:10.3109/14397595.2013.844306

95. TianXP, ZhangX. Gastrointestinal involvement in systemic lupus erythematosus: insight into pathogenesis, diagnosis and treatment. World J Gastroenterol2010;16:2971. CrossRef

96. MillerMH, UrowitzMB, GladmanDD, et al.The liver in systemic lupus erythematosus. Q J Med1984;53:401.

97. HallS, CzajaAJ, KaufmanDK, et al.How lupoid is lupoid hepatitis?J Rheumatol1986;13:95.

98. HaslockI. Spontaneous rupture of the liver in systemic lupus erythematosus. Ann Rheum Dis1974;33:482. CrossRef

99. KivirikkoKI. Collagens and their abnormalities in a wide spectrum of diseases. Ann Med1993;25:113. CrossRef

100. PepinM, SchwarzeU, Superti‐FurgaA, et al.Clinical and genetic features of Ehlers‐Danlos syndrome type IV, the vascular type. N Engl J Med2000;342:673. CrossRef

101. SolomonJA, AbramsL, LichtensteinGR. GI manifestations o Ehlers‐Danlos syndrome. Am J Gastroenterol1996;91:2282.

102. HorowitzM, McNeilJD, MaddernGJ, et al.Abnormalities of gastric and esophageal emptying in polymyositis and dermatomyositis. Gastroenterology1986;90:434.

103. MarieI, HatronPY, LevesqueH, et al.Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine (Baltimore)1999;78:139. CrossRef

104. EbertEC. Gastrointestinal and hepatic manifestations of Sjogren syndrome. J Clin Gastroenterol2012;46:25. CrossRef

105. IltanenS, CollinP, KorpelaM, et al.Celiac disease and markers of celiac disease latency in patients with primary Sjögren's syndrome. Am J Gastroenterol1999;94:1042.

106. DörnerT, HeldC, TrebeljahrG, et al.Serologic characteristics in primary biliary cirrhosis associated with sicca syndrome. Scand J Gastroenterol1994;29:655. CrossRef

107. ZochlingJ, SmithEU. Seronegative spondyloarthritis. Best Pract Res Clin Rheumatol2010;24:747. CrossRef

108. RudwaleitM, BaetenD. Ankylosing spondylitis and bowel disease. Best Pract Res Clin Rheumatol2006;20:451. CrossRef

109. ScottWWJr, FishmanEK, KuhlmanJE, et al.Computed tomography evaluation of thesacroiliac joints in Crohn disease. Radiologic/clinical correlation. Skeletal Radiol1990;19:207. CrossRef

110. MarshallJB, KretschmarJM, GerhardtDC, et al.Gastrointestinal manifestations mixed connective tissue disease. Gastroenterology1990;98:1232.

111. WalshNM, BodurthaA. Auerbach's myenteric plexus. A possible site of origin for gastrointestinal stromal tumors in von Recklinghausen's neurofibromatosis. Arch Pathol Lab Med1990;114:522.

112. BakkerJR, HaberMM, GarciaFU. Gastrointestinal neurofibromatosis: an unusual cause of gastric outlet obstruction. Am Surg2005;71:100.

113. GalloroG, MignognaM, de WerraC, et al.The role of upper endoscopy in identifying oesophageal involvement in patients with oral pemphigus vulgaris. Dig Liver Dis2005;37:195. CrossRef

114. SuO, OnsunN, Meric TekerA, et al.Upper airway tract and upper gastrointestinal tract involvement in patients with pemphigus vulgaris. Eur J Dermatol2010;20:792.

115. FreemanEB, KöglmeierJ, MartinezAE, et al.Gastrointestinal complications of epidermolysis bullosa in children. Br J Dermatol2008;158:1308. CrossRef

116. McDonaldJ, Bayrak‐ToydemirP, PyeritzRE. Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management, and pathogenesis. Genet Med2011;13:607. CrossRef

117. GrèveE, MoussataD, GaudinJL, et al.High diagnostic and clinical impact of small‐bowel capsule endoscopy in patients with hereditary hemorrhagic telangiectasia with overt digestive bleeding and/or severe anemia. Gastrointest Endosc2010;71:760. CrossRef

118. IanoraAA, MemeoM, SabbaC, et al.Hereditary hemorrhagic telangiectasia: multi‐detector row helical CT assessment of hepatic involvement. Radiology2004;230:250. CrossRef

119. LarsonAM. Liver disease in hereditary hemorrhagic telangiectasia. J Clin Gastroenterol2003;36:149. CrossRef

120. LetkoE, PapaliodisDN, PapaliodisGN, et al.Stevens‐Johnson syndrome and toxic epidermal necrolysis: a review of the literature. Ann Allergy Asthma Immunol2005;94:419. CrossRef

121. ZweibanB, CohenH, ChandrasomaP. Gastrointestinal involvement complicating Stevens‐Johnson syndrome. Gastroenterology1986;91:469.

122. OkanG, YaylaciS, PekerO, et al.Vanishing bile duct and Stevens‐Johnson syndrome associated with ciprofloxacin treated with tacrolimus. World J Gastroenterol2008;14:4697. CrossRef

123. AssierH, Bastuji‐GarinS, RevuzJ, et al.Erythema multiforme with mucous membrane involvement and Stevens–Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol1995;131:539. CrossRef

124. SokumbiO, WetterDA. Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist. Int J Dermatol2012;51:889. CrossRef

125. JenkinsPJ, FaircloughPD, British Society for Gastroenterology, Association of Coloproctology for Great Britain and Ireland. Screening guidelines for colorectal cancer and polyps in patients with acromegaly. Gut2002;51(Suppl 5):V13. CrossRef

126. EzzatS. Hepatobiliary and gastrointestinal manifestations of acromegaly. Dig Dis1992;10:1731. CrossRef

127. OldenburgWA, van HeerdenJA, SizemoreGW, et al.Hypercalcemia and primary hepatic tumors. Arch Surg1982;117:1363. CrossRef

128. EbertEC. The parathyroids and the gut. J Clin Gastroenterol2010;44:479.

129. PaloyanD, SimonowitzD, PaloyanE, et al.Pancreatitis associated with primary hyperparathyroidism. Am Surg1982;48:366.

130. AbboudB, DaherR, BoujaoudeJ. Digestive manifestations of parathyroid disorders. World J Gastroenterol2011;17:4063. CrossRef

131. IsaiaGC, CasalisS, GrossoI, et al.Hypoparathyroidism and co‐existing celiac disease. J Endocrinol Invest2004;27:778. CrossRef

132. EbertEC. The thyroid and the gut. J Clin Gastroenterol2010;44:402.

133. EastwoodGL, BravermanLE, WhiteEM, et al.Reversal of lower esophageal sphincter hypotension and esophageal aperistalsis after treatment for hypothyroidism. J Clin Gastroenterol1982;4:307. CrossRef

134. BakerJT, HarveyRF. Bowel habit in thyrotoxicosis and hypothyroidism. Br Med J1971;1:322. CrossRef

135. AbbasiAA, DouglassRC, BissellGW, et al.Myxedema ileus. A form of intestinal pseudo‐obstruction. JAMA1975;234:181. CrossRef

136. BergeronE, MitchellA, HeyenF, et al.Acute colonic surgery and unrecognized hypothyroidism: a warning. Report of six cases. Dis Colon Rectum1997;40:859. CrossRef

137. de CastroF, BonaciniM, WaldenJM, et al.Myxedema ascites. Report of two cases and review of the literature. J Clin Gastroenterol1991;13:411. CrossRef

138. KocenRS, AtkinsonM. Ascites in hypothyroidism. Lancet1963;1:527. CrossRef

139. WeetmanAP. Graves' disease. N Engl J Med2000;343:1236. CrossRef

140. ModebeO. Autoimmune thyroid disease with ulcerative colitis. Postgrad Med J1986;62:475. CrossRef

141. AndersonJR, GrayKG, MiddletonDG, et al.Autoimmunity and thyrotoxicosis. Br Med J1964;2:1630. CrossRef

142. ScarfM. Gastrointestinal manifestations of hyperthyroidism. J Lab Clin Med1936;21:1253.

143. WegenerM, WedmannB, LanghoffT, et al.Effect of hyperthyroidism on the transit of a caloric solid‐liquid meal through the stomach, the small intestine, and the colon in man. J Clin Endocrinol Metab1992;75:745.

144. FongTL, McHutchisonJG, ReynoldsTB. Hyperthyroidism and hepatic dysfunction. A case series analysis. J Clin Gastroenterol1992;14:240. CrossRef

145. MenconiF, HashamA, TomerY. Environmental triggers of thyroiditis: hepatitis C and interferon‐α. J Endocrinol Invest2011;34:78. CrossRef

146. GlinoerD, CooperDS. The propylthiouracil dilemma. Curr Opin Endocrinol Diabetes Obes2012;19:402. CrossRef

147. SteinfeldCM, MoertelCG, WoolnerLB. Diarrhea and medullary carcinoma of the thyroid. Cancer1973;31:1237. CrossRef

148. McConaheyWM, HayID, WoolnerLB, et al.Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc1986;61:978. CrossRef

149. AlfonsoA, ChristoudiasG, AmaruddinQ, et al.Tracheal or esophageal compression due to benign thyroid disease. Am J Surg1981;142:350. CrossRef

150. BeauregardC, DicksteinG, LacroixA. Classic and recent etiologies of Cushing's syndrome: diagnosis and therapy. Treat Endocrinol2002;1:79. CrossRef

151. TobinMV, AldridgeSA, MorrisAI, et al.Gastrointestinal manifestations of Addison's disease. Am J Gastroenterol1989;84:1302.

152. BoultonR, HamiltonMI, DhillonAP, et al.Subclinical Addison's disease: a cause of persistent abnormalities in transaminase values. Gastroenterology1995;109:1324. CrossRef

153. SkoogSM, Foxx‐OrensteinAE, LevyMJ, et al.Intestinal endometriosis: the great masquerader. Curr Gastroenterol Rep2004;6:405. CrossRef

154. LarsenP, KronenbergH, MelmedS, et al. (eds). Williams Textbook of Endocrinology. 12th ed.Philadelphia: Elsevier/Saunders; 2011: 1371.

155. WildS, RoglicG, GreenA, et al.Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care2004;27:1047. CrossRef

156. WHO. Comparitive quantification of health risks: global and regional burden of disease attributable to selected major risk factors. Geneva: WHO; 2004.

157. BurcelinR, SerinoM, ChaboC, et al.Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta Diabetol2011;48:257. CrossRef

158. TalleyNJ, ZinmeisterAR, SchleckCD, et al.Dyspepsia and dyspepsia sub‐groups: a population based study. Gastroenterology1992;102:1259.

159. TalleyNJ, BoyceP, JonesM. Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population. Gut1998;42:690. CrossRef

160. BytzerMD, TalleyNJ, LeemonM, et al.Prevalence of gastrointestinal symptoms associated with diabetes mellitus. A population‐based survey of 15000 adults. Arch Intern Med2001;161:1989. CrossRef

161. MalekiD, LockeGRIII, CamilleriM, et al.Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med2000;160:2808. CrossRef

162. SpangeusA, El‐SalhyM, SuhrO, et al.Prevalence of gastrointestinal symptoms in yound and middle‐aged diabetic patients. Scand J Gastroenterol1999;35:152.

163. ClouseRE, ListmanPJ. Gastrointestinal symptoms in diabetic patients: lack of association with neuropathy. Am J Gastroenterol1989;84:868.

164. MayneN. Neuropathy in the diabetic and non‐diabetic populations. Lancet1965;2:1313. CrossRef

165. The Diabetes Control and Complications Trial Group. The effect of intensive diabetes therapy on the development an progression of neuropathy. Ann Intern Med1995;122:561. CrossRef

166. CallaghanBC, LittleAA, FeldmanEL, et al.Enhanced glucose control for preventing and treating diabetic neuropathy.Cochrane Database Syst Rev. 2012;(6):CD007543.

167. CamilleriM. Gastrointestinal problems in diabetes. Endocr Metab Clin N Am1996;25:361. CrossRef

168. ChangEB, FedorakRN, FieldM. Experimental diabetic diarrhea in rats: Intestinal mucosal denervation, hyposensitivity and treatment with clonidine. Gastroenterology1986;91:564

169. BytzerP, TalleyNJ, HammerJ, et al.GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complication. Am J Gastroenterol2002;97:604. CrossRef

170. FraserRJ, HorowitzM, MaddoxAF, et al.Hyperglycemia shows gastric emptying in type I (insulin‐dependent) diabetes mellitus. Diabetologia1989;32:151. CrossRef

171. JebbinkRJA, SamsonM, BruijsPPM, et al.Hyperglycemia induces abnormalities of gastric myoelectrical activity in patients with diabetes mellitus. Gastroenterology1994;107:1390. CrossRef

172. SimsM, HaslerW, CheyWD, et al.Acute hyperglycemia inhibits gastrocolonic and colonic perstaltic reflexes measured by an electronic barostat in healthy humans. Gastroenterology1994:106:A566.

173. SellinJH, ChangEB. Therapy Insight: gastrointestinal complications of diabetes–pathophysiology and management. Nat Clin Pract Gastroenterol Hepatol2008;3:162. CrossRef

174. MoscosoGJ, DriverM, GuyRJ. A form of necrobiosis and atrophy of smooth muscle in diabetic gastric autonomic neuropathy. Pathol Res Pract1986;181:188. CrossRef

175. HorváthVJ, VittalH, LörinczA. Reduced stem cell factor links smooth myopathy and loss of interstitial cells of cajal in murine diabetic gastroparesis. Gastroenterology2006;130:759. CrossRef

176. LeinningerGM, EdwardsJL, LipshawMJ, et al.Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy. Nat Clin Pract Neurol2006;2:620. CrossRef

177. BrownleeM. Glycation products and the pathogenesis of diabetic complications. Diabetes Care1992;15:1835. CrossRef

178. RaynerCK, SamsomM, JonesKL, et al.Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care2001;24:371. CrossRef

179. LluchI, AscasoJF, MoraF, et al.Gastroesophageal reflux in diabetes mellitus. Am J Gastroenterol1999;94:919. CrossRef

180. SchvarczE, PalmerM, AmanJ, et al.Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin‐dependent diabetes mellitus. Gastroenterology1997;113:60. CrossRef

181. FraserRJ, HorowitzM, MaddoxAF, et al.Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis–effects of cisapride. Gut1994;35:172. CrossRef

182. JanatuinenE, PikkarainenP, LaaksoM, et al.Gastrointestinal symptoms in middle‐aged diabetic patients. Scand J Gastroenterol1993;28:427. CrossRef

183. CamilleriM. Diabetic gastroparesis. New Engl J Med2007;356:820. CrossRef

184. AbellTL, CamilleriM, DonohoeK, et al.Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. J Nucl Med Technol2008;36:44. CrossRef

185. RydallAC, RodinGM, OlmstedMP, et al.Disordered eating behavior and microvascular complications in young women with insulin‐dependent diabetes mellitus. N Engl J Med1997;336:1849. CrossRef

186. PinderRM, BrogdenRN, SawyerPR, et al.Metoclopramide: a review of its pharmacological properties and clinical use. Drugs1976;12:81. CrossRef

187. JanssensJ, PeetersTL, VantrappenG, et al.Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med1990;322:1028. CrossRef

188. AlamU, AsgharO, MalikRA. Diabetic gastroparesis: therapeutic options. Diabetes Ther2010;1:32. CrossRef

189. McCallumRW, PrakashC, Campoli‐RichardsDM, et al.Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders. Drugs1988;36:652. CrossRef

190. MurrayCD, MartinNM, PattersonM, et al.Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut2005;54:1693. CrossRef

191. EjskjaerN, DimcevskiG, WoJ, et al.Safety and efficacy of ghrelin agonist TZP‐101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo‐controlled study. Neurogastroenterol Motil2010;22:1069. CrossRef

192. BromerMQ, FriedenbergF, MillerLS, et al.Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc2005;61:833. CrossRef

193. ArtsJ, HolvoetL, CaenepeelP, et al.Clinical trial: a randomized‐controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther2007;26:1251. CrossRef

194. FriedenbergFK, PalitA, ParkmanHP, et al.Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol2008;103:416. CrossRef

195. AbellT, McCallumR, HockingM, et al.Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology2003;125:421. CrossRef

196. JonesMP, MagantiK. A systematic review of surgical therapy for gastroparesis. Am J Gastroenterol2003;98:2122. CrossRef

197. MehraS, TavakoliM, KallinikosPA, et al.Corneal confocal microscopy detects early nerve regeneration after pancreas transplantation in patients with type 1 diabetes. Diabetes Care2007;30:2608. CrossRef

198. LysyJ, IsraeliE, GoldinE. The prevalence of chronic diarrhea among diabetic patients. Am J Gastroenterol1999;94:2165. CrossRef

199. TalalAH, MurrayJA, GoekenJA, et al.Celiac disease in an adult population with insulin‐dependent diabetes mellitus: use of endomysial antibody testing. Am J Gastroenterol1997;92:1280.

200. EwaldN, BretzelRG, FantusIG, et al.Pancreatin therapy in patients with insulin‐treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of a prospective multi‐centre trial. Diabetes Metab Res Rev2007;23:386. CrossRef

201. FedorakRN, FieldM, ChangEB. Treatment of diabetic diarrhea with clonidine. Ann Intern Med1985;102:197. CrossRef

202. MouradFH, GorardD, ThillainayagamAV, et al.Effective treatment of diabetic diarrhoea with somatostatin analogue, octreotide. Gut1992;33:1578. CrossRef

203. BattleWM, SnapeWJJr, AlaviA, et al.Colonic dysfunction in diabetes mellitus. Gastroenterology1980;79:1217.

204. AmbizasEM, GinzburgR. Lubiprostone: a chloride channel activator for treatment of chronic constipation. Ann Pharmacother2007;41:957. CrossRef

205. SchillerLR, Santa AnaCA, SchmulenAC, et al.Pathogenesis of fecal incontinence in diabetes mellitus: evidence for internal‐anal‐sphincter dysfunction. N Engl J Med1982;307:1666. CrossRef

206. FillmannHS, LlessuyS, MarroniCA, et al.Diabetes mellitus and anal sphincter pressures: an experimental model in rats. Dis Colon Rectum2007;50:517. CrossRef

207. SunWM, KatsinelosP, HorowitzM, et al.Disturbances in anorectal function in patients with diabetes mellitus and faecal incontinence. Eur J Gastroenterol Hepatol1996;8:1007. CrossRef

208. RansohoffDF, MillerGL, ForsytheSB, et al.Outcome of acute cholecystitis in patients with diabetes mellitus. Ann Intern Med1987;106:829. CrossRef

209. AnguloP. Nonalcoholic fatty liver disease. N Engl J Med2002;346:1221. CrossRef

210. LattuadaG, RagognaF, PerseghinG. Why does NAFLD predict type 2 diabetes?Curr Diab Rep2011;11:167. CrossRef

211. AdamsLA, LympJF, St SauverJ, et al.The natural history of nonalcoholic fatty liver disease: a population‐based cohort study. Gastroenterology2005;129:113. CrossRef

212. AngelicoF, BurattinM, AlessandriC, et al.Drugs improving insulin resistance for non‐alcoholic fatty liver disease and/or non‐alcoholic steatohepatitis. Cochrane Database Syst Rev2007;(1):CD005166.

213. WeinstockJV. Immunoregulation of granulomatous inflammation in the liver and intestines. In: MarshMN(ed). Immunopathology of the Small Intestine. London: John Wiley & Sons; 1987: 151.

214. HarringtonPT, GutierrezJJ, Ramirez‐RondaRH, et al.Granulomatous hepatitis. Rev Infect Dis1982;4:638. CrossRef

215. TjwaM, De HertoghG, NeuvilleB, et al.Hepatic fibrin‐ring granulomas and granulomatous hepatitis. Acta Clin Belg2001;56:341. CrossRef

216. BhargavaDK, KushwahaAKS, DasarathyS, et al.Endoscopic diagnosis of segmental colonic tuberculosis. Gastrointest Endosc1992;38:571. CrossRef

217. RybickiBA, MajorM, PopovichJJr, et al.Racial differences in sarcoidosis incidence: A 5‐year study in a health maintenance organization. Am J Epidemiol1997;145:234. CrossRef

218. KennedyPT, ZakariaN, ModawiSB, et al.Natural history of hepatic sarcoidosis and its response to treatment. Eur J Gastroenterol Hepatol2006;18:721. CrossRef

219. AdlaM, DowneyKK, AhmadJ. Hepatic, sarcoidosis associated with pegylated interferon alfa therapy for chronic hepatitis C: case report and review of the literature. Dig Dis Sci2008;53:2810. CrossRef

220. MaddreyWC, JohnsCJ, BoitnottJK, et al.Sarcoidosis and chronic hepatic disease: A clinical and pathologic study of 20 patients. Medicine1970;49:375. CrossRef

221. IshakKG. Sarcoidosis of the liver and bile ducts. Mayo Clin Proc1998;73:467. CrossRef

222. WarshauerDM, MolinaPL, HammanSM, et al.Nodular sarcoidosis of the liver and spleen: analysis of 32 cases. Radiology1995;195:757. CrossRef

223. AlamI, LevensonSD, FerrellLD, et al.Diffuse intrahepatic biliary strictures in sarcoidosis resembling sclerosing cholangitis. Case report and review of the literature. Dig Dis Sci1997;42:1295. CrossRef

224. ZoutmanDE, RalphED, FreiJV. Granulomatous hepatitis and fever of unknown origin. An 11‐year experience of 23 cases with three years' follow‐up. J Clin Gastroenterol1991;13:69. CrossRef

225. VallaD, Pessegueiro‐MirandaH, DegottC, et al.Hepatic sarcoidosis with portal hypertension. A report of seven cases with a reviewof the literature. Q J Med1987;63:531.

226. KelbyML, McHardyRJ. An unusual case of fatal hepatic sarcoidosis. Am J Med1955;18:842. CrossRef

227. BarbersPG. Role of transplantation (lung, liver, and heart) in sarcoidosis. Clin Chest Med1997;18:865. CrossRef

228. FarmanJ, RamirezG, RybakB, et al.Gastric sarcoidosis. Abdom Imaging1997;22:248. CrossRef

229. OnaFV. Gastric sarcoid: unusual cause of upper gastrointestinal hemorrhage. Am J Gastroenterol1981;75:286.

230. ChinitzMA, BrandtLJ, FrankMS, et al.Symptomatic sarcoidosis of the stomach. Dig Dis Sci1985;30:682. CrossRef

231. FellermannK, StahlM, DahlhoffK, et al.Crohn's disease and sarcoidosis: Systemic granulomatosis?Eur J Gastroenterol Hepatol1997;9:1121. CrossRef

232. BacalD, HoshalVLJr, SchaldenbrandJD, et al.Sarcoidosis of the pancreas: Case report and review of the literature. Am Surg2000;66:675.

233. ReiderHL, SniderDE, CauthenGM. Extrapulmonary tuberculosis in the United States. Am Rev Respir Dis1990;141:347. CrossRef

234. ShahS, ThomasV, MathanM, et al.Colonoscopic study of 50 patients with colonic tuberculosis. Gut1992;33:347. CrossRef

235. PulimoodAB, PeterS, RamakrishnaB, et al.Segmental colonoscopic biopsies in the differentiation of ileocolonic tuberculosis from Crohn's disease. J Gastroenterol Hepatol2005;20:688. CrossRef

236. GanHT, ChenYQ, OuyangQ, et al.Differentiation between intestinal tuberculosis and Crohn's disease in endoscopic biopsy specimens by polymerase chain reaction. Am J Gastroenterol2002;97:1446. CrossRef

237. MuneefMA, MemishZ, MahmoudSA, et al.Tuberculosis in the belly: a review of forty‐six cases involving the gastrointestinal tract and peritoneum. Scand J Gastroenterol2001;36:528. CrossRef

238. SteinbergMH. Management of sickle cell disease. N Engl J Med1999;340:1021. CrossRef

239. BaumgartnerF, KleinS. The presentation and management of the acute abdomen in the patient with sickle‐cell anemia. Am Surg1989;55:660.

240. KoskinasJ, ManesisEK, ZacharakisGH, et al.Liver involvement in acute vaso‐occlusive crisis of sickle cell disease: prevalence and predisposing factors. Scand J Gastroenterol2007;42:499. CrossRef

241. BerryPA, CrossTJ, TheinSL, et al.Hepatic dysfunction in sickle cell disease: a new system of classification based on global assessment. Clin Gastroenterol Hepatol2007;5:1469. CrossRef

242. OmataM, JohnsonCS, TongM, et al.Pathological spectrum of liver diseases in sickle cell disease. Dig Dis Sci1986;31:247. CrossRef

243. DarbariDS, Kple‐FagetP, KwagyanJ, et al.Circumstances of death in adult sickle cell disease patients. Am J Hematol2006;81:858. CrossRef

244. DeVaultKR, FriedmanLS, WesterbergS, et al.Hepatitis C in sickle cell anemia. J Clin Gastroenterol1994;18:206. CrossRef

245. EbertEC, NagarM, HagspielKD. Gastrointestinal and hepatic complications of sickle cell disease. Clin Gastroenterol Hepatol2010;8:483. CrossRef

246. TaherA, El RassiF, Isma'eelH, et al.Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia. Haematologica2008;93:1584. CrossRef

247. RicchiP, AmmirabileM, SpasianoA, et al.Combined chelation therapy in thalassemia major with deferiprone and desferrioxamine: a retrospective study. Eur J Haematol2010;85:36.

248. EysterME, AsaadSM, GoldBD, et al.Upper gastrointestinal bleeding in haemophiliacs: incidence and relation to use of non‐steroidal anti‐inflammatory drugs. Haemophilia2007;13:279. CrossRef

249. PiccioliA, LensingAW, PrinsMH, et al.Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial. J Thromb Haemost2004;2:884. CrossRef

250. BernsteinCN, BlanchardJF, HoustonDS, et al.The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: apopulation‐based cohort study. Thromb Haemost2001;85:430.

251. Di. FabioF, LykoudisP, GordonPH. Thromboembolism in inflammatory bowel disease: an insidious association requiring a high degree of vigilance. Semin Thromb Hemost2011;37:220. CrossRef

252. GraingeMJ, WestJ, CardTR. Venous thromboembolism during active disease and remission in inflammatory bowel disease. Lancet2010;375:657. CrossRef

253. KaplanBS, MeyersKE, SchulmanSL. The pathogenesis and treatment of hemolytic uremic syndrome. J Am Soc Nephrol1998;9:1126.

254. KosterF, LevinJ, WalkerL, et al.Hemolytic‐uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. N Engl J Med1978;298:927. CrossRef

255. BakerNM, MillsAE, RachmanI, et al.Haemolytic‐uraemic syndrome in typhoid fever. Br Med J1974;2:84. CrossRef

256. CohenMB, GiannellaRA. Hemorrhagic colitis associated with Escherichia coli O157:H7. Adv Intern Med1992;37:173.

257. IlnyckyjA, GreenbergH, BernsteinCN. Escherichia coli O157:H7 infection mimicking Crohn's disease. Gastroenterology1997;112:995. Erratum in: Gastroenterology 1997 Jul;113(1):368. CrossRef

258. TrachtmanH, ChristenE. Pathogenesis, treatment, and therapeutic trials in hemolytic uremic syndrome. Curr Opin Pediatr1999;11:162. CrossRef

259. SafdarN, SaidA, GangnonRE, et al.Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta‐analysis. JAMA2002;288:996. CrossRef

260. SmithKE, WilkerPR, ReiterPL, et al.Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota. Pediatr Infect Dis J2012;31:37. CrossRef

261. MichaelM, ElliottEJ, CraigJC, et al.Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials. Am J Kidney Dis2009;53:259. CrossRef

262. VeselySK, GeorgeJN, LämmleB, et al.ADAMTS13 activity in thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood2003;102:60. CrossRef

263. AllfordSL, HuntBJ, RoseP, et al.Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol2003;120:556. CrossRef

264. ChapmanK, SeldonM, RichardsR. Thrombotic microangiopathies, thrombotic thrombocytopenic purpura, and ADAMTS‐13. Semin Thromb Hemost2012;38:47. CrossRef

265. TsaiHM, LianEC. Antibodies to von Willebrand factor‐cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med1998;339:1585. CrossRef

266. LämmleB, GeorgeJN. Thrombotic thrombocytopenic purpura: advances in pathophysiology, diagnosis, and treatment‐introduction. Semin Hematol2004;41:1. CrossRef

267. NovacekG. Plummer‐Vinson syndrome. Orphanet J Rare Dis2006;1:36. CrossRef

268. WynderEL, HultbergS, JacobssonF, et al.Environmental factors in cancer of the upper alimentary tract; a Swedish study with special reference to Plummer‐Vinson (Paterson‐Kelly) syndrome. Cancer1957;10:470. CrossRef

269. SipeJD, BensonMD, BuxbaumJN, et al.Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis. Amyloid2010;17:101. CrossRef

270. MolleeP. How to diagnose amyloidosis. Intern Med J2014;44:7. CrossRef

271. FalkRH, ComenzoRL, SkinnerM. The systemic amyloidoses. N Engl J Med1997;337:898. CrossRef

272. YamadaM, HatakeyamaS, TsukagoshiH. Gastrointestinal amyloid deposition in AL (primary or myeloma‐associated) and AA (secondary) amyloidosis: Diagnostic value of gastric biopsy. Hum Pathol1985;16:1206. CrossRef

273. MenkeDM, KyleRA, FlemingCR, et al.Symptomatic gastric amyloidosis in patients with primary systemic amyloidosis. Mayo Clin Proc1993;68:763. CrossRef

274. HaymanSR, LacyMQ, KyleRA, et al.Primary systemic amyloidosis: a cause of malabsorption syndrome. Am J Med2001;111:535. CrossRef

275. CarlsonHC, BreenJF. Amyloidosis and plasma cell dyscrasias: gastrointestinal involvement. Semin Roentgenol1986;21:128. CrossRef

276. ParkMA, MuellerPS, KyleRA, et al.Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients. Medicine2003;82:291. CrossRef

277. RockeyDC. Striking cholestatic liver disease: A distinct manifestation of advanced primary amyloidosis. South Med J1999;92:236. CrossRef

278. BuckFS, KossMN. Hepatic amyloidosis: morphologic differences between systemic AL and AA types. Hum Pathol1991;22:904. CrossRef

279. KyleRA, GertzMA. Primary systemic amyloidosis: Clinical and laboratory features in 474 cases. Semin Hematol1995;32:45.

280. GertzMA. Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment. Am J Hematol2013;88:416. CrossRef

281. ZemerD, PrasM, SoharE, et al.Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med1986;314:1001. CrossRef

282. DavidJ. Amyloidosis in juvenile chronic arthritis. Clin Exp Rheumatol1991;9:73.

283. DenisMA, CosynsJP, PersuA, et al.Control of AA amyloidosis complicating Crohn's disease: a clinico‐pathological study. Eur J Clin Invest2013;43:292. CrossRef

284. HerleniusG, WilczekHE, LarssonM, et al.Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry. Transplantation2004;77:64. CrossRef

285. LightdaleCJ, KurtzRC, SherlockP, et al.Aggressive endoscopy in critically ill patients with upper gastrointestinal bleeding and cancer. Gastrointest Endosc1974;20:152. CrossRef

286. BrooksJJ, EnterlineHT. Primary gastric lymphomas. a clinicopathologic study of 58 cases with long‐term follow‐up and literature review. Cancer1983;51:701. CrossRef

287. ThomasCRJr, CarterIK, LeslieWT, et al.Common emergencies in cancer medicine: hematologic and gastrointestinal syndromes. J Natl Med Assoc1992;84:165.

288. ChuDZ, ShivshankerK, StroehleinJR, et al.Thrombocytopenia and gastrointestinal hemorrhage in the cancer patient: prevalence of unmasked lesions. Gastrointest Endosc1983;29:269. CrossRef

289. ChuangVP, WallaceS, StroehleinJ, et al.Hepatic artery infusion chemotherapy: gastroduodenal complications. AJR Am J Roentgenol1981;137:347. CrossRef

290. GomezL, MartinoR, RosltonKV. Neutropenic enterocolitis spectrum of disease and comparison of definite and possible cases. Clin Infect Dis1998;27:695. CrossRef

291. SloasMM, FlynnPM, KasteSC, et al.Typhlitis in children with cancer: a 30‐year experience. Clin Infect Dis1993;17:484. CrossRef

292. McCarvilleMB, AdelmanCS, LiC, et al.Typhlitis in childhood cancer. Cancer2005;104:380. CrossRef

293. KatzJA, WagnerML, GresikMV, et al.Typhlitis. An 18‐year experience and postmortem review. Cancer1990;65:1041. CrossRef

294. WadeDS, NavaHR, DouglassHO. Neutropenic enterocolitis: clinical diagnosis and treatment. Cancer1992;69:17. CrossRef

295. GallickHL, WeaverDW, SachsRJ, et al.Intestinal obstruction in cancer patients. An assessment of risk factors and outcome. Am Surg1986;52:434.

296. TangE, DavisJ, SilbermanH. Bowel obstruction in cancer patients. Arch Surg1995;130:832. CrossRef

297. OsteenRT, GuytonS, SteeleGJr, et al.Malignant intestinal obstruction. Surgery1980;87:611.

298. EsperDH, HarbWA. The cancer cachexia syndrome: a review of metabolic and clinical manifestations. Nutr Clin Pract2005;20:369. CrossRef

299. ToomeyD, RedmondHP, Bouchier‐HayesD. Mechanisms mediating cancer cachexia. Cancer1995;76:2418. CrossRef

300. DonohoeCL, RyanAM, ReynoldsJV. Cancer cachexia: mechanisms and clinical implications. Gastroenterol Res Pract2011;2011:601434. CrossRef

301. McMillanDC. An inflammation‐based prognostic score and its role in the nutrition‐based management of patients with cancer. Proc Nutr Soc2008;67:257. CrossRef

302. RubinH. Cancer cachexia: its correlations and causes. Proc Natl Acad Sci U S A2003;100:5384. CrossRef

303. DewysWD, BeggC, LavinPT, et al.Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med1980;69:491. CrossRef

304. Plata‐SalamánCR. Central nervous system mechanisms contributing to the cachexia‐anorexia syndrome. Nutrition2000;16:1009. CrossRef

305. BaldwinC. Nutritional support for malnourished patients with cancer. Curr Opin Support Palliat Care2011;5:29. CrossRef

306. MantovaniG, MadedduC. Cancer cachexia: medical management. Support Care Cancer2010;18:1. CrossRef

307. BensonAB3rd, AjaniJA, CatalanoRB, et al.Recommended guidelines for the treatment of cancer treatment‐induced diarrhea. J Clin Oncol2004;22:2918. CrossRef

308. KamthanAG, BrucknerHW, HirschmanSZ, et al.Clostridium difficile diarrhea induced by cancer chemotherapy. Arch Intern Med1992;152:1715. CrossRef

309. van VlietMJ, HarmsenHJ, de BontES, et al.The role of intestinal microbiota in the development and severity of chemotherapy‐induced mucositis. PLoS Pathog2010;6:e1000879. CrossRef

310. SonisST. The pathobiology of mucositis. Nat Rev Cancer2004;4:277. CrossRef

311. WorthingtonHV, ClarksonJE, BryanG, et al.Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev2011;(4):CD000978.

312. Raber‐DurlacherJE, von BültzingslöwenI, LoganRM, et al.Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients. Support Care Cancer2013;21:343. CrossRef

313. BainesMJ. ABC of palliative care. Nausea, vomiting, and intestinal obstruction. BMJ1997;315:1148. CrossRef

314. CubedduLX. Serotonin mechanisms in chemotherapy‐induced emesis in cancer patients. Oncology1996;53(Suppl 1):18. CrossRef

315. HeskethPJ. Potential role of the NK1 receptor antagonists in chemotherapy‐induced nausea and vomiting. Support Care Cancer2001;9:350. CrossRef

316. MarkmanM. Progress in preventing chemotherapy‐induced nausea and vomiting. Cleve Clin J Med2002;69:609. CrossRef

317. MorrowGR, MorrellC. Behavioral treatment for the anticipatory nausea and vomiting induced by cancer chemotherapy. N Engl J Med1982;307:1476. CrossRef

318. DiBaiseJK. Paraneoplastic gastrointestinal dysmotility: when to consider and how to diagnose. Gastroenterol Clin North Am2011;40:777. CrossRef

319. De GiorgioR, GuerriniS, BarbaraG, et al.Inflammatory neuropathies of the enteric nervous system. Gastroenterology2004;126:1872. CrossRef

320. KiersL, AltermattHJ, LennonVA. Paraneoplastic anti‐neuronal nuclear IgG autoantibodies (type 1) localize antigen in small cell lung carcinoma. Mayo Clin Proc1991;66:1209. CrossRef

321. LucchinettiCF, KimmelDW, LennonVA. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear antibodies. Neurology1998;50:652. CrossRef

322. LennonVA, KryzerTJ, GriesmannGE, et al.Calcium‐channel antibodies in the Lambert‐Eaton syndrome and other paraneoplastic syndromes. N Engl J Med1995;332:1467. CrossRef

323. LeeHR, LennonVA, CamilleriM, et al.Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics. Am J Gastroenterol2001;96:373. CrossRef

324. SaidSI. Evidence for secretion of vasoactive intestinal peptide by tumours of pancreas, adrenal medulla, thyroid and lung: support for the unifying APUD concept. Clin Endocrinol (Oxf)1976;5(Suppl):201S. CrossRef

325. WashingtonK, McDonaghD. Secondary tumors of the gastrointestinal tract: surgical pathologic findings and comparison with autopsy survey. Mod Pathol1995;8:427.

326. AdsayNV, AndeaA, BasturkO, et al.Secondary tumors of the pancreas: an analysis of a surgical and autopsy database and review of the literature. Virchows Arch2004;444:527. CrossRef

327. IdelevichE, KashtanH, MavorE, et al.Small bowel obstruction caused by secondary tumors. Surg Oncol2006;15:29. CrossRef

328. HerbsmanH, WetsteinL, RosenY, et al.Tumors of the small intestine. Curr Probl Surg1980;17:121. CrossRef

329. EbertEC, HagspielKD. Gastrointestinal manifestations of leukemia. J Gastroenterol Hepatol2012;27:458. CrossRef

330. CornesJS, JonesTG. Leukaemic lesions of the gastrointestinal tract. J Clin Pathol1962;15:305. CrossRef

331. ProllaJC, KirsnerJB. The Gastrointestinal lesions and complications of leukemias. Ann Intern Med1964;61:1084. CrossRef

332. GivlerRL. Esophageal lesions in leukemia and lymphoma. Am J Dig Dis1970;15:31. CrossRef

333. ErasP, GoldsteinMJ, SherlockP. Candida infection of the gastrointestinal tract. Medicine1972;51:367. CrossRef

334. AndersonSH, RichardsonP, WendonJ, et al.Acute liver failure as the initial manifestation of acute leukaemia. Liver2001;21:287. CrossRef

335. HawkinsJA, MowerWR, NelsonEW. Acute abdominal conditions in patients with leukemia. Am J Surg1985;150:739. CrossRef

336. MicozziA, CartoniC, MonacoM, et al.High incidence of infectious gastrointestinal complications observed in patients with acute myeloid leukemia receiving intensive chemotherapy for first induction of remission. Support Care Cancer1996;4:294. CrossRef

337. CastrellonA, FeldmanPA, SuarezM, et al.Crohn's disease complicated by primary gastrointestinal Hodgkin's lymphoma presenting with small bowel perforation. J Gastrointestin Liver Dis2009;18:359.

338. KadinME, DonaldsonSS, DorfmanRF, et al.Isolated granulomas in Hodgkin's disease. N Engl J Med1970;283:859. CrossRef

339. AisenbergAC, KaplanMM, RiederSV, et al.Serum alkaline phosphatase at the onset of Hodgkin's disease. Cancer1970;26:318. CrossRef

340. SilecchiaG, RaparelliL, PerrottaN, et al.Accuracy of laparoscopy in the diagnosis and staging of lymphoproliferative diseases. World J Surg2003;27:653. CrossRef

341. TrotterMC, CloudGA, DavisM, et al.Predicting the risk of abdominal disease in Hodgkin's lymphoma. A multifactorial analysis of staging laparotomy results in 255 patients. Ann Surg1985;201:465. CrossRef

342. RosenbergS, DiamondHD, JaslowitzJ, et al.Lymphosarcoma: a review of 1269 cases. Medicine1961;40:31. CrossRef

343. EhrlichAN, StalderG, GellerW, et al.Gastrointestinal manifestations of malignant lymphoma. Gastroenterology1968;54:1115.

344. ValentiniM, BortoluzziF, CannizzaroR, et al.Gastroduodenal involvement in staging of nodal non‐Hodgkin lymphomas: a clinical and endoscopic prospective study of 235 patients. Am J Gastroenterol1995;90:1959.

345. LavergneA, BroulandJP, LaunayE, et al.Multiple lymphomatous polyposis of the gastrointestinal tract. An extensive histopathologic and immunohistochemical study of 12 cases. Cancer1994;74:3042. CrossRef

346. WoolfGM, PetrovicLM, RojterSE, et al.Acute liver failure due to lymphoma. A diagnostic concern when considering liver transplantation. Dig Dis Sci1994;39:1351. CrossRef

347. FerreriAJ, GoviS, PileriSA. Hepatosplenic gamma‐delta T‐cell lymphoma. Crit Rev Oncol Hematol2012;83:283. CrossRef

348. KotlyarDS, OstermanMT, DiamondRH, et al.A systematic review of factors that contribute to hepatosplenic T‐cell lymphoma in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol2011;9:36. CrossRef

349. TalamoG, CavalloF, ZangariM, et al.Clinical and biological features of multiple myeloma involving the gastrointestinal system. Haematologica2006;91:964.

350. ThomasFB, ClausenKP, GreenbergerNJ. Liver disease in multiple myeloma. Arch Intern Med1973;132:195. CrossRef

351. Perez‐SolerR, EstebanR, AllendeE, et al.Liver involvement in multiple myeloma. Am J Hematol1985;20:25. CrossRef

352. GradisharW, RecantW, ShapiroC. Obstructing plasmacytoma of the duodenum: first manifestation of relapsed multiple myeloma. Am J Gastroenterol1988;83:77.

353. KyleRA, GreippPR. Amyloidosis (AL). Clinical and laboratory features in 229 cases. Mayo Clin Proc1983;58:665.

354. DimopoulosMA, AnagnostopoulosA. Waldenström's macroglobulinemia. Best Pract Res Clin Haematol2005;18:747. CrossRef

355. KailaVL, el NewihiHM, DreilingBJ, et al.Waldenström's macroglobulinemia of the stomach presenting with upper gastrointestinal hemorrhage. Gastrointest Endosc1996;44:73. CrossRef

356. FineKD, StoneMJ. Alpha‐heavy chain disease, Mediterranean lymphoma, and immunoproliferative small intestinal disease: a review of clinicopathological features, pathogenesis, and differential diagnosis. Am J Gastroenterol1999;94:1139.

357. HalphenM, NajjrT, JaafouraH, et al.Diagnostic value of upper intestinal fiber endoscopy in primary small intestinal lymphoma. A prospective study by the Tunisian‐French Intestinal Lymphoma Group. Cancer1986;58:2140. CrossRef

358. Wahner‐RoedlerDL, WitzigTE, LoehrerLL, et al.Gamma‐heavy chain disease: review of 23 cases. Medicine2003;82:236.

359. TefferiA, VardimanJW. Classification and diagnosis of myeloproliferative neoplasms. Leukemia2008;22:14. CrossRef

360. TefferiA. Primary myelofibrosis: 2012 update on diagnosis, risk stratification, and management. Am J Hematol2011;86:1017. CrossRef

361. ChatelainD, DevendevilleA, RudelliA, et al.Gastric myeloid metaplasia: a case report and review of the literature. Arch Pathol Lab Med2004;128:568.

362. VannucchiAM, AntonioliE, GuglielmelliP, et al.Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal. Leukemia2008;22:1299. CrossRef

363. Guppo Italiano Studio Policitemia. Polycythemia vera: the natural history of 1213 patients followed for 20 years. Ann Intern Med1995;123:656. CrossRef

364. WolanskyjAP, LashoTL, SchwagerSM, et al.JAK2 mutation in essential thrombocythaemia: clinical associations and long‐term prognostic relevance. Br J Haematol2005;131:208. CrossRef

365. BrièreJB. Budd‐Chiari syndrome and portal vein thrombosis associated with myeloproliferative disorders: diagnosis and management. Semin Thromb Hemost2006;32:208. CrossRef

366. MillerB, MorrisM, RutledgeF, et al.Aborted exenterative procedures in recurrent cervical cancer. Gynecol Oncol1993;50:94. CrossRef

367. RockallAG, GhoshS, Alexander‐SefreF, et al.Can MRI rule out bladder and rectal invasion in cervical cancer to help select patients for limited EUA?Gynecol Oncol2006;101:244. CrossRef

368. EifelPJ, LevenbackC, WhartonJT, et al.Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys1995;32:1289. CrossRef

369. HuangEY, LinH, HsuHC, et al.High external parametrial dose can increase the probability of radiation proctitis in patients with uterine cervix cancer. Gynecol Oncol2000;79:406. CrossRef

370. KrebsHB, GoplerudDR. Mechanical intestinal obstruction in patients with gynecologic disease: a review of 368 patients. Am J Obstet Gynecol1987;157:577. CrossRef

371. PothuriB, MontemaranoM, GerardiM, et al.Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma. Gynecol Oncol2005;96:330. CrossRef

372. RaoA, LandR, CarterJ. Management of upper gastrointestinal obstruction in advanced ovarian cancer with intraluminal stents. Gynecol Oncol2004;95:739. CrossRef

373. CheongJH, HyungWJ, ChenJ, et al.Surgical management and outcome of metachronous Krukenberg tumors from gastric cancer. J Surg Oncol2004;87:39. CrossRef

374. LensM, BatailleV, KrivokapicZ. Melanoma of the small intestine. Lancet Oncol2009;10:516. CrossRef

375. ReintgenDS, ThompsonW, GarbuttJ, et al.Radiologic, endoscopic, and surgical considerations of melanoma metastatic to the gastrointestinal tract. Surgery1984;95:635.

376. TessierDJ, McConnellEJ, Young‐FadokT, et al.Melanoma metastatic to the colon: case series and review of the literature with outcome analysis. Dis Colon Rectum2003;46:441. CrossRef

377. AllenPJ, CoitDG. The surgical management of metastatic melanoma. Ann Surg Oncol2002;9:762. CrossRef

378. PardananiA. Systemic mastocytosis: disease overview, pathogenesis, and treatment. Hematol Oncol Clin North Am2012;26:1117. CrossRef

379. SokolH, Georgin‐LavialleS, Grandpeix‐GuyodoC, et al.Gastrointestinal involvement and manifestations in systemic mastocytosis. Inflamm Bowel Dis2010;16:1247. CrossRef

380. JensenRT. Gastrointestinal abnormalities and involvement in systemic mastocytosis. Hematol Oncol Clin North Am2000;14:579. CrossRef

381. PoynardT, NatafC, MessingB, et al.Secretory diarrhea and prostaglandin D2 overproduction in systemic mastocytosis. N Engl J Med1982;307:186.

382. ValentP, AkinC, EscribanoL, et al.Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest2007;37:435. CrossRef

383. Lynch‐NyhanA, FishmanEK, KadirS. Diagnosis and management of massive gastrointestinal bleeding owing to duodenal metastasis from renal cell carcinoma. J Urol1987;138:611.

384. DelpreG, IlieB, PapoJ, et al.Hypernephroma with nonmetastatic liver dysfunction (Stauffer's syndrome) and hypercalcemia. Case report and review of the literature. Am J Gastroenterol1979;72:239.

385. AoyagiT, MoriI, UeyamaY, et al.Sinusoidal dilatation of the liver as a paraneoplastic manifestation of renal cell carcinoma. Hum Pathol1989;20:1193. CrossRef

386. RasquinA, Di LorenzoC, ForbesD, et al.Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology2006;130:1527. CrossRef

387. WorawattanakulM, RhoadsJM, LichtmanSN, et al.Abdominal migraine: prophylactic treatment and follow‐up. J Pediatr Gastroenterol Nutr1999;28:37. CrossRef

388. TanV, SahamiAR, PeeblesR, et al.Abdominal migraine and treatment with intravenous valproic Acid. Psychosomatics2006;47:353. CrossRef

389. RobertsJE, DeshazoRD. Abdominal migraine, another cause of abdominal pain in adults. Am J Med2012;125:1135. CrossRef

390. PeppercornMA, HerzogAG. The spectrum of abdominal epilepsy in adults. Am J Gastroenterol1989;84:1294.

391. SrinivasanR, GreenbaumDS. Chronic abdominal wall pain: a frequently overlooked problem. Practical approach to diagnosis and management. Am J Gastroenterol2002;97:824.

392. SchallerBJ, GrafR, JacobsAH. Pathophysiological changes of the gastrointestinal tract in ischemic stroke. Am J Gastroenterol2006;101:1655. CrossRef

393. SmithardDG, O'NeillPA, ParkC, et al.Complications and outcome after acute stroke: does dysphagia matter?Stroke1996;27:1200. CrossRef

394. MillerAJ. Deglutition. Physiol Rev1982;62:129.

395. IdjadiF, RobbinsR, StahlWM, et al.Prospective study of gastric secretion in stressed patients with intracranial injury. J Trauma1971;11:681. CrossRef

396. WijdicksEF, FulghamJR, BattsKP. Gastrointestinal bleeding in stroke. Stroke1994;25:2146. CrossRef

397. WieselPH, NortonC, GlickmanS, et al.Pathophysiology and management of bowel dysfunction in multiple sclerosis. Eur J Gastroenterol Hepatol2001;13:441. CrossRef

398. FowlerCJ, HenryMM. Gastrointestinal dysfunction in multiple sclerosis. Semin Neurol1996;16:277. CrossRef

399. CaruanaBJ, WaldA, HindsJP, et al.Anorectal sensory and motor function in neurogenic fecal incontinence. Comparison between multiple sclerosis and diabetes mellitus. Gastroenterology1991;100:465.

400. GillKP, ChiaYW, HenryMM, et al.Defecography in multiple sclerosis patients with severe constipation. Radiology1994;191:553. CrossRef

401. WieselPH, NortonC, RoyAJ, et al.Gut focused behavioural treatment (biofeedback) for constipation and faecal incontinence in multiple sclerosis. J Neurol Neurosurg Psychiatry2000;69:240. CrossRef

402. FillitHM, DoodyRS, BinasoK, et al.Recommendations for best practices in the treatment of Alzheimer's disease in managed care. Am J Geriatr Pharmacother2006;4(Suppl A):S9. CrossRef

403. CholongitasE, PipiliC, DasenakiM. Recurrence of upper gastrointestinal bleeding after donepezil administration. Alzheimer Dis Assoc Disord2006;20:326. CrossRef

404. WuJH, GuoZ, KumarS, et al.Incidence of serious upper and lower gastrointestinal events in older adults with and without Alzheimer's disease. J Am Geriatr Soc2011;59:2053. CrossRef

405. GillickMR. Rethinking the role of tube feeding in patients with advanced dementia. N Engl J Med2000;342:206. CrossRef

406. KomiyaK, IshiiH, TeramotoS, et al.Medical professionals' attitudes toward tube feeding for themselves or their families: a multicenter survey in Japan. J Palliat Med2012;15:561. CrossRef

407. SampsonEL, CandyB, JonesL. Enteral tube feeding for older people with advanced dementia. Cochrane Database Syst Rev2009;(2):CD007209.

408. CullenS. Gastrostomy tube feeding in adults: the risks, benefits and alternatives. Proc Nutr Soc2011;70:293. CrossRef

409. MatsumuraJS, PrystowskyJB, BrestickerMA, et al.Gastrointestinal tract complications after acute spine injury. Arch Surg1995;130:751. CrossRef

410. EbertE. Gastrointestinal involvement in spinal cord injury: a clinical perspective. J Gastrointestin Liver Dis2012;21:75.

411. HaasU, GengV. Sensation of defecation in patients with spinal cord injury. Spinal Cord2008;46:107. CrossRef

412. FajardoNR, PasiliaoRV, Modeste‐DuncanR, et al.Decreased colonic motility in persons with chronic spinal cord injury. Am J Gastroenterol2003;98:128. CrossRef

413. LombardiG, Del PopoloG, CecconiF, et al.Clinical outcome of sacral neuromodulation in incomplete spinal cord‐injured patients suffering from neurogenic bowel dysfunctions. Spinal Cord2010;48:154. CrossRef

414. PfeifferRF. Gastrointestinal dysfunction in Parkinson's disease. Parkinsonism Relat Disord2011;17:10. CrossRef

415. Plowman‐PrineEK, SapienzaCM, OkunMS, et al.The relationship between quality of life and swallowing in Parkinson's disease. Mov Disord2009;24:1352. CrossRef

416. BornLJ, HarnedRH, RikkersLF, et al.Cricopharyngeal dysfunction in Parkinson's disease: role in dysphagia and response to myotomy. Mov Disord1996;11:53. CrossRef

417. BassottiG, MaggioD, BattagliaE, et al.Manometric investigation of anorectal function in early and late stage Parkinson's disease. J Neurol Neurosurg Psychiatry2000;68:768. CrossRef

418. ChelimskyG, WszolekZ, ChelimskyTC, et al.Gastrointestinal dysfunction in autonomic neuropathy. Semin Neurol1996;16:259. CrossRef

419. FreemanR. Autonomic peripheral neuropathy. Lancet2005;365:1259. CrossRef

420. SandroniP, VerninoS, KleinCM, et al.Idiopathic autonomic neuropathy: comparison of cases seropositive and seronegative for ganglionic acetylcholine receptor antibody. Arch Neurol2004;61:44. CrossRef

421. JansenRW, LipsitzLA. Postprandial hypotension: epidemiology, pathophysiology, and clinical management. Ann Intern Med1995;122:286. CrossRef

422. McDougallAJ, McLeodJG. Autonomic neuropathy, II: Specific peripheral neuropathies. J Neurol Sci1996;138:1. CrossRef

423. BertiniE, D'AmicoA, GualandiF, et al.Congenital muscular dystrophies: a brief review. Semin Pediatr Neurol2011;18:277. CrossRef

424. BensenES, JaffeKM, TarrPI. Acute gastric dilatation in Duchenne muscular dystrophy: a case report and review of the literature. Arch Phys Med Rehabil1996;77:512. CrossRef

425. LeonSH, SchufflerMD, KettlerM, et al.Chronic intestinal pseudoobstruction as a complication of Duchenne's muscular dystrophy. Gastroenterology1986;90:455.

426. NowakTV, IonasescuV, AnurasS. Gastrointestinal manifestations of the muscular dystrophies. Gastroenterology1982;82:800.

427. RönnblomA, DanielssonA. Hereditary muscular diseases and symptoms from the gastrointestinal tract. Scand J Gastroenterol2004;39:1.

428. ModolellI, MearinF, BaudetJS, et al.Pharyngo‐esophageal motility disturbances in patients with myotonic dystrophy. Scand J Gastroenterol1999;34:878. CrossRef

429. EckardtVF, NixW. The anal sphincter in patients with myotonic muscular dystrophy. Gastroenterology1991;100:424.

430. KasarskisEJ, ScarlataD, HillR, et al.A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials. J Neurol Sci1999;169:118. CrossRef

431. WallaceDC. Diseases of the mitochondrial DNA. Annu Rev Biochem1992;61:1175. CrossRef

432. MuellerLA, CamilleriM, Emslie‐SmithAM. Mitochondrial neurogastrointestinal encephalomyopathy: manometric and diagnostic features. Gastroenterology1999;116:959. CrossRef

433. GuptaS, SaverymuttuSH, GibbsJS, et al.Watery diarrhea in a patient with myasthenia gravis, thymoma, and immunodeficiency. Am J Gastroenterol1985;80:877.

434. ReintamA, ParmP, KitusR, et al.Gastrointestinal symptoms in intensive care patients. Acta Anaesthesiol Scand2009;53:318. CrossRef

435. FruhwaldS, KainzJ. Effect of ICU interventions on gastrointestinal motility. Curr Opin Crit Care2010;16:159. CrossRef

436. Reintam BlaserA, MalbrainML, StarkopfJ, et al.Gastrointestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM Working Group on Abdominal Problems. Intensive Care Med2012;38:384. CrossRef

437. ReidCL, CampbellIT, LittleRA. Muscle wasting and energy balance in critical illness. Clin Nutr2004;23:273. CrossRef

438. GinerM, LavianoA, MeguidMM, et al.In 1995 a correlation between malnutrition and poor outcome in critically ill patients still exists. Nutrition1996;12:23. CrossRef

439. McClaveSA, MartindaleRG, VanekVW, et al.Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr2009;33:277. CrossRef

440. KangW, KudskKA. Is there evidence that the gut contributes to mucosal immunity in humans?JPEN J Parenter Enteral Nutr2007;31:246. CrossRef

441. CaddellKA, MartindaleR, McClaveSA, et al.Can the intestinal dysmotility of critical illness be differentiated from postoperative ileus?Curr Gastroenterol Rep2011;13:358. CrossRef

442. StupakDP, AbdelsayedGG, SolowayGN. Motility disorders of the upper gastrointestinal tract in the intensive care unit: pathophysiology and contemporary management. J Clin Gastroenterol2012;46:449. CrossRef

443. HammasB, ThörnSE, WattwilM. Propofol and gastric effects of morphine. Acta Anaesthesiol Scand2001;45:1023. CrossRef

444. CastedalM, BjörnssonE, AbrahamssonH. Effects of midazolam on small bowel motility in humans. Aliment Pharmacol Ther2000;14:571. CrossRef

445. RasmussenL, Oster‐JørgensenE, QvistN, et al.The effects of omeprazole on intragastric pH, intestinal motility, and gastric emptying rate. Scand J Gastroenterol1999;34:671. CrossRef

446. NguyenNQ, FraserRJ, BryantLK, et al.The impact of delaying enteral feeding on gastric emptying, plasma cholecystokinin, and peptide YY concentrations in critically ill patients. Crit Care Med2008;36:1469. CrossRef

447. HenrionJ, DescampsO, LuwaertR, et al.Hypoxic hepatitis in patients with cardiac failure: incidence in a coronary care unit and measurement of hepatic blood flow. J Hepatol1994;21:696. CrossRef

448. CookGC. Liver involvement in systemic infection. Eur J Gastroenterol Hepatol1997;9:1239.

449. ChandN, SanyalAJ. Sepsis‐induced cholestasis. Hepatology2007;45:230. CrossRef

450. GreenRM, BeierD, GollanJL. Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology1996;111:193. CrossRef

451. WhitingJF, GreenRM, RosenbluthAB, et al.Tumor necrosis factor‐alpha decreases hepatocyte bile salt uptake and mediates endotoxin‐induced cholestasis. Hepatology1995;22:1273.

452. ZimmermanH. Jaundice due to bacterial infection. Gastroenterology1979;77:362.

453. FaustTW, ReddyKR. Postoperative jaundice. Clin Liver Dis2004;8:151. CrossRef

454. LaMontJT. Postoperative jaundice. Surg Clin North Am1974;54:637.

455. SeetoRK, FennB, RockeyDC. Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med2000;109:109. CrossRef

456. GreeneNM. Halothane anesthesia and hepatitis in a high‐risk population. N Engl J Med1973;289:304. CrossRef

457. DuffieldRA. Cystic fibrosis and the gastrointestinal tract. J Pediatr Health Care1996;10:51. CrossRef

458. StrongTV, BoehmK, CollinsFS. Localization of cystic fibrosis transmembrane conductance regulator mRNA in the human gastrointestinal tract by in situ hybridization. J Clin Invest1994;93:347. CrossRef

459. ShalonLB, AdelsonJW. Cystic fibrosis. Gastrointestinal complications and gene therapy. Pediatr Clin North Am1996;43:157. CrossRef

460. FitzSimmonsSC. The changing epidemiology of cystic fibrosis. J Pediatr1993;122:1. CrossRef

461. ModolellI, AlvarezA, GuarnerL, et al.Gastrointestinal, liver, and pancreatic involvement in adult patients with cystic fibrosis. Pancreas2001;22:395. CrossRef

462. DrayX, BienvenuT, Desmazes‐DufeuN, et al.Distal intestinal obstruction syndrome in adults with cystic fibrosis. Clin Gastroenterol Hepatol2004;2:498. CrossRef

463. MousaHM, WoodleyFW. Gastroesophageal reflux in cystic fibrosis: current understandings of mechanisms and management. Curr Gastroenterol Rep2012;14:226. CrossRef

464. MatelJL, MillaCE. Nutrition in cystic fibrosis. Semin Respir Crit Care Med2009;30:579. CrossRef

465. Lloyd‐StillJD, BenoDW, KimuraRM. Cystic fibrosis colonopathy. Curr Gastroenterol Rep1999;1:231. CrossRef

466. TangprichaV, KellyA, StephensonA, et al.An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence‐based recommendations from the Cystic Fibrosis Foundation. J Clin Endocrinol Metab2012;97:1082. CrossRef

467. MoyerK, BalistreriW. Hepatobiliary disease in patients with cystic fibrosis. Curr Opin Gastroenterol2009;25:272. CrossRef

468. NegliaJP, FitzSimmonsSC, MaisonneuveP, et al.The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med1995;332:494. CrossRef

469. JohannessonM, AsklingJ, MontgomerySM, et al.Cancer risk among patients with cystic fibrosis and their first‐degree relatives. Int J Cancer2009;125:2953. CrossRef

470. SchnatzPF, CastellJA, CastellDO. Pulmonary symptoms associated with gastroesophageal reflux: use of ambulatory pH monitoring to diagnose and to direct therapy. Am J Gastroenterol1996;91:1715.

471. HerveP, DenjeanA, JianR, et al.Intraesophageal perfusion of acid increases the bronchomotor response to methacholine and to isocapnic hyperventilation in asthmatic subjects. Am Rev Respir Dis1986;134:986. CrossRef

472. McCallisterJW, ParsonsJP, MastronardeJG. The relationship between gastroesophageal reflux and asthma: an update. Ther Adv Respir Dis2011;5:143. CrossRef

473. BusseWW, LemanskeRFJr. Expert panel report 3: moving forward to improve asthma care. J Allergy Clin Immunol2007;120:1012. CrossRef

474. American Lung Association Asthma Clinical Research Centers, MastronardeJG, AnthonisenNR, et al.Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med2009;360:1487. CrossRef

475. SontagSJ, O'ConnellS, MillerTQ, et al.Asthmatics have more nocturnal gasping and reflux symptoms than nonasthmatics, and they are related to bedtime eating. Am J Gastroenterol2004;99:789. CrossRef

476. KiljanderTO. The role of proton pump inhibitors in the management of gastroesophageal reflux disease‐related asthma and chronic cough. Am J Med2003;115(Suppl 3A):65S. CrossRef

477. RichterJE. Gastroesophageal reflux disease and asthma: the two are directly related. Am J Med2000;108(Suppl 4a):153S. CrossRef

478. MelloCJ, IrwinRS, CurleyFJ. Predictive values of the character, timing, and complications of chronic cough in diagnosing its cause. Arch Intern Med1996;156:997. CrossRef

479. StemmermannGN, MarcusEB, BuistAS, et al.Relative impact of smoking and reduced pulmonary function on peptic ulcer risk. A prospective study of Japanese men in Hawaii. Gastroenterology1989;96:1419.

480. MendesD, CorreiaM, BarbedoM, et al.Behçet's disease–a contemporary review. J Autoimmun2009;32:178. CrossRef

481. VerityDH, MarrJE, OhnoS, et al.Behcet's disease, the Silk Road and HLA‐B51: historical and geographical perspectives. Tissue Antigens1999;54:213. CrossRef

482. KasaharaY, TanakaS, NishinoM, et al.Intestinal involvement in Behçet's disease: review of 136 surgical cases in the Japanese literature. Dis Colon Rectum1981;24:103. CrossRef

483. BayraktarY, BalkanciF, BayraktarM, et al.Budd‐Chiari syndrome: a common complication of Behçet's disease. Am J Gastroenterol1997;92:858.

484. AbrilA. Churg‐strauss syndrome: an update. Curr Rheumatol Rep2011;13:489. CrossRef

485. SinicoRA, Di TomaL, MaggioreU, et al.Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg‐Strauss syndrome. Arthritis Rheum2005;52:2926. CrossRef

486. StoneJH, MerkelPA, SpieraR, et al.Rituximab versus cyclophosphamide for ANCA‐associated vasculitis. N Engl J Med2010;363:221. CrossRef

487. AkbulutS. Multiple ileal perforations in a patient with Wegener's granulomatosis: a case report and literature review. J Gastrointest Surg2012;16:857. CrossRef

488. StewartC, CohenD, BhattacharyyaI, et al.Oral manifestations of Wegener's granulomatosis: a report of three cases and a literature review. J Am Dent Assoc2007;138:338. CrossRef

489. FallowsGA, HamiltonSF, TaylorDS, et al.Esophageal involvement in Wegener's granulomatosis: a case report and review of the literature. Can J Gastroenterol2000;14:449.

490. JennetteJC, FalkRJ. Small‐vessel vasculitis. N Engl J Med1997;337:1512. CrossRef

491. TrepoC, GuillevinL. Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis. J Autoimmun2001;16:269. CrossRef

492. EbertEC, HagspielKD, NagarM, et al.Gastrointestinal involvement in polyarteritis nodosa. Clin Gastroenterol Hepatol2008;6:960. CrossRef

493. GuillevinL, Le Thi HuongD, GodeauP, et al.Clinical findings and prognosis of polyarteritis nodosa and Churg‐Strauss angiitis: a study in 165 patients. Br J Rheumatol1988;27:258. CrossRef

494. LevineSM, HellmannDB, StoneJH. Gastrointestinal involvement in polyarteritis nodosa (1986–2000): presentation and outcomes in 24 patients. Am J Med2002;112:386. CrossRef

495. JennetteJ, FalkR, BaconP, et al.2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum2013;65:1. doi: 10.1002/art.37715. CrossRef

496. ZuradaJM, WardKM, GrossmanME. Henoch‐Schönlein purpura associated with malignancy in adults. J Am Acad Dermatol2006;55(Suppl):S65. CrossRef

497. OzenS, RupertoN, DillonMJ, et al.EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis2006;65:936. CrossRef

498. EsakiM, MatsumotoT, NakamuraS, et al.GI involvement in Henoch‐Schönlein purpura. Gastrointest Endosc2002;56:920. CrossRef

499. TrapaniS, MicheliA, GrisoliaF, et al.Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5‐year period and review of literature. Semin Arthritis Rheum2005;35:143. CrossRef

500. Gonzalez‐GayMA, LlorcaJ. Controversies on the use of corticosteroid therapy in children with Henoch‐Schönlein purpura. Semin Arthritis Rheum2005;35:135. CrossRef

501. Ramos‐CasalsM, StoneJH, CidMC, et al.The cryoglobulinaemias. Lancet2012;379:348. CrossRef

502. TakadaS, ShimizuT, HadanoY, et al.Cryoglobulinemia (review). Mol Med Rep2012;6:3.

503. MillsPR, SturrockRD. Clinical associations between arthritis and liver disease. Ann Rheum Dis1982;41:295. CrossRef

504. KoschkeM, BoettgerMK, SchulzS, et al.Autonomy of autonomic dysfunction in major depression. Psychosom Med2009;71:852. CrossRef

505. ParianteCM, LightmanSL. The HPA axis in major depression: classical theories and new developments. Trends Neurosci2008;31:464. CrossRef

506. TachéY, PerdueMH. Role of peripheral CRF signalling pathways in stress‐related alterations of gut motility and mucosal function. Neurogastroenterol Motil2004;16(Suppl 1):137. CrossRef

507. TachéY, BonazB. Corticotropin‐releasing factor receptors and stress‐related alterations of gut motor function. J Clin Invest2007;117:33. CrossRef

508. BlanchardEB, ScharffL, SchwarzSP, et al.The role of anxiety and depression in the irritable bowel syndrome. Behav Res Ther1990;28:401. CrossRef

509. DrossmanDA, McKeeDC, SandlerRS, et al.Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology1988;95:701.

510. WhiteheadWE, BosmajianL, ZondermanAB, et al.Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples. Gastroenterology1988;95:709.

511. WhiteheadWE, CrowellMD, RobinsonJC, et al.Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut1992;33:825. CrossRef

512. LydiardRB, FosseyMD, MarshW, et al.Prevalence of psychiatric disorders in patients with irritable bowel syndrome. Psychosomatics1993;34:229. CrossRef

513. DrossmanDA, WhiteheadWE, CamilleriM. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology1997;112:2120. CrossRef

514. MittermaierC, DejacoC, WaldhoerT, et al.Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18‐month follow‐up study. Psychosom Med2004;66:79. CrossRef

515. NigroG, AngeliniG, GrossoSB, et al.Psychiatric predictors of noncompliance in inflammatory bowel disease: psychiatry and compliance. J Clin Gastroenterol2001;32:66. CrossRef

516. JankeKH, KlumpB, GregorM, et al.Determinants of life satisfaction in inflammatory bowel disease. Inflamm Bowel Dis2005;11:272. CrossRef

517. FarrokhyarF, MarshallJK, EasterbrookB, et al.Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health. Inflamm Bowel Dis2006;12:38. CrossRef

518. BernsteinCN, SinghS, GraffLA, et al.A prospective population‐based study of triggers of symptomatic flares in IBD. J Gastroenterol2010;105:1994.

519. WalkerJR, EdigerJP, GraffLA, et al.The Manitoba IBD cohort study: a population‐based study of the prevalence of lifetime and 12‐month anxiety and mood disorders. Am J Gastroenterol2008;103:1989. CrossRef

520. KurinaLM, GoldacreMJ, YeatesD, et al.Depression and anxiety in people with inflammatory bowel disease. J Epidemiol Community Health2001;55:716. CrossRef

521. Fuller‐ThomsonE, SulmanJ. Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflamm Bowel Dis2006;12:697. CrossRef

522. ChangL, AdeyemoM, KaragiannidesI, et al.Serum and colonic mucosal immune markers in irritable bowel syndrome. Am J Gastroenterol2012;107:262. CrossRef

523. GraffLA, WalkerJR, BernsteinCN. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis2009;15:1105. doi: 10.1002/ibd.20873; Review. CrossRef

524. PorcelliP, LeociC, GuerraV. A prospective study of the relationship between disease activity and psychologic distress in patients with inflammatory bowel disease. Scand J Gastroenterol1996;31:792. CrossRef

525. RatnaikeRN. Acute and chronic arsenic toxicity. Postgrad Med J2003;79:391. CrossRef

526. Guha MazumderDN. Chronic arsenic toxicity: clinical features, epidemiology, and treatment: experience in West Bengal. J Environ Sci Health A Tox Hazard Subst Environ Eng2003;38:14. CrossRef

527. Guha MamzumderDN. Arsenic and liver disease. J Indian Med Assoc2001;99:314.

528. PhilippR. Arsenic exposure: health effects and the risk of cancer. Rev Environ Health1985;5:27.

529. MichetCJ, RakelaJ, LuthraMD. Auranofin‐associated colitis and eosinophilia. Mayo Clin Proc1987;62:142. CrossRef

530. BassetC, VadrotJ, DenisJ, et al.Prolonged cholestasis and ductopenia following gold salt therapy. Liver Int2003;23:89. CrossRef

531. TongS, von SchirndingYE, PrapamontolT. Environmental lead exposure: a public health problem of global dimensions. Bull WHO2000;78:1068.

532. IbelsLS, PollockCA. Lead intoxication. Med Toxicol1986;1:387.

533. KaliaK, FloraSJ. Strategies for the safe and effective therapeutic measures for chronic arsenic and lead poisoning. J Occup Health2005;47:1. CrossRef